Executives
-
Graham Jonathan PEVP & Gen. Counsel & Secy. -
Khosla RachnaSVP, Business Development
-
Busch Matthew C.VP, Finance & CAO
-
Grygiel Nancy A.SVP & CCO
-
Santos EstebanEVP, Operations
-
Reese David MEVP & Chief Technology Officer
-
Miller DerekSVP, Human Resources
-
Griffith Peter H.EVP & CFO
-
Gordon MurdoEVP, Global Commercial Ops
-
Bradner James E.EVP, R&D, & Chief Sci. Officer
?
Drake Michael V
Director
Amgen Inc.
US, Thousand Oaks [HQ]
CIK
1938942
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
31,747,662
Price per Share :
$272.11
Equivalence :
$8,638,856,306.82
Transaction History
-
A31,747,662 Shares After TransactionValue : $n/a$0.0Transaction Date : 05/31/24
-
Footnotes
-
-
Footnotes:#1 The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule.#2 These shares include 92 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.
-
A33,072,967 Shares After TransactionValue : $n/a$0.0Transaction Date : 08/09/24
-
Footnotes
-
-
Footnotes:#1 The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule#2 These shares include 116 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.
-
A24,557,662 Shares After TransactionValue : $n/a$0.0Transaction Date : 05/07/24
-
Footnotes
-
-
Footnotes:#1 The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSU's may be deferred by the director, in which case payment will occur according to the elected deferral schedule.#2 These shares include 92 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.
-
A35,521,796 Shares After TransactionValue : $n/a$0.0Transaction Date : 11/04/24
-
Footnotes
-
-
Footnotes:#1 The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule#2 These shares include 140 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.